Evogene Ltd. (EVGN) vs 60 Degrees Pharmaceuticals, Inc. (SXTP)
A side-by-side comparison of Evogene Ltd. and 60 Degrees Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EVGN
Evogene Ltd.
$0.42HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SXTP
60 Degrees Pharmaceuticals, Inc.
$1.13HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
Total return — EVGN vs SXTP
growth of $100 · dividends reinvested · last 3yEVGN -96.5% (-67.3%/yr)SXTP -99.9% (-89.1%/yr)EVGN compounded faster over this window
Log scale — wide-divergence pair
EVGN SXTP
EVGN vs SXTP: by the numbers
- •SXTP is the larger company ($4M vs $4M market cap).
- •Both run net losses; EVGN's is the smaller (-694.19% vs -730.23% net margin).
- •EVGN grew revenue faster over the past five years (2.86% vs -14.35% CAGR).
Metrics side by side
Valuation
| Metric | EVGN | SXTP |
|---|---|---|
| P/S ratio | 2.79 | 3.56 |
Profitability
| Metric | EVGN | SXTP |
|---|---|---|
| Gross margin | -6.25% | 19.42% |
| Operating margin | -364.24% | -774.90% |
| Net margin | -694.19% | -730.23% |
| ROE | N/A | -310.33% |
| ROIC | -130.12% | -321.28% |
Growth (annualized)
| Metric | EVGN | SXTP |
|---|---|---|
| Revenue CAGR (5Y) | 2.86% | -14.35% |
| Total return CAGR (5Y) | -56.46% | N/A |
Frequently asked
- Which has grown faster, EVGN or SXTP?
- Over the past five years, EVGN grew revenue faster — EVGN at a 2.86% CAGR versus SXTP at -14.35%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.